Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Zhe-Tuo Qi"'
Autor:
Guanghan Fan, Xuyong Wei, Shusen Zheng, Haiyang Xie, Chenzhi Zhang, Rongli Wei, Xiao Xu, Zhe-Tuo Qi
Publikováno v:
Hepatobiliary & Pancreatic Diseases International. 20:433-451
Background Nonalcoholic fatty liver disease and its advanced stage, nonalcoholic steatohepatitis (NASH), are the major cause of hepatocellular carcinoma (HCC) and other end-stage liver disease. However, the potential mechanism and therapeutic strateg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dce6430425428d57c3456db05084c04
https://doi.org/10.1016/j.hbpd.2021.06.001
https://doi.org/10.1016/j.hbpd.2021.06.001
Autor:
Linsong Tang, Zuyuan Lin, Kangchen Chen, Weimin Fan, Li Xu, Haiyang Xie, Guanghan Fan, Shusen Zheng, Xiao Xu, Rongli Wei, Xuyong Wei, Zhensheng Zhang, Junbin Zhou, Zhe-Tuo Qi, Xuechun Cai, Chenzhi Zhang
Publikováno v:
Free Radical Biology and Medicine. 167:1-11
Rapamycin is a crucial immunosuppressive regimen for patients that have undergone liver transplantation (LT). However, one of the major side effects of rapamycin include metabolic disorders such as dyslipidemia, and the mechanism remains unknown. Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8578d7ab59f56bd97ec77b73f40736c4
https://doi.org/10.1016/j.freeradbiomed.2021.02.033
https://doi.org/10.1016/j.freeradbiomed.2021.02.033